v3.23.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Oct. 29, 2023
Oct. 30, 2022
Cash flows from operating activities    
Net income $ 880,722 $ 734,989
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 276,094 211,629
lululemon Studio obsolescence provision 23,709 0
Impairment of assets and restructuring costs 74,501 0
Gain on disposal of assets 0 (10,180)
Stock-based compensation expense 70,157 59,487
Settlement of derivatives not designated in a hedging relationship 29,499 (19,202)
Changes in operating assets and liabilities:    
Inventories (301,801) (832,024)
Prepaid and receivable income taxes (114,616) (77,458)
Prepaid expenses and other current assets 41,202 (90,512)
Other non-current assets (30,513) (25,725)
Accounts payable 141,685 26,537
Accrued liabilities and other (16,238) 31,767
Accrued compensation and related expenses (1,496) (13,694)
Current and non-current income taxes payable (153,539) (54,354)
Unredeemed gift card liability (35,927) (33,481)
Right-of-use lease assets and current and non-current lease liabilities 19,898 15,285
Other current and non-current liabilities 8,729 (2,865)
Net cash provided by (used in) operating activities 912,066 (79,801)
Cash flows from investing activities    
Purchase of property and equipment (445,353) (431,677)
Settlement of net investment hedges 686 29,158
Other investing activities (658) 15,657
Net cash used in investing activities (445,325) (386,862)
Cash flows from financing activities    
Proceeds from settlement of stock-based compensation 24,937 10,243
Shares withheld related to net share settlement of stock-based compensation (30,877) (34,695)
Repurchase of common stock (504,643) (374,976)
Net cash used in financing activities (510,583) (399,428)
Effect of foreign currency exchange rate changes on cash and cash equivalents (19,887) (41,156)
Increase (decrease) in cash and cash equivalents (63,729) (907,247)
Cash and cash equivalents, beginning of period 1,154,867 1,259,871
Cash and cash equivalents, end of period $ 1,091,138 $ 352,624